Aficamten is associated with improvements in cardiac mechanics in obstructive hypertrophic cardiomyopathy: Results from FOREST-HCM.
- DOI
- 10.1016/j.pcad.2026.08.013
- Published
- 2026 Aug 25
- Container
- Progress in cardiovascular diseases
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.pcad.2026.08.013,
title = {Aficamten is associated with improvements in cardiac mechanics in obstructive hypertrophic cardiomyopathy: Results from FOREST-HCM.},
author = {Chen ML and Hodovan J and Masri A and Liu V and Kim MO and Melloni C and Jacoby DL and Heitner SB and Abraham TP},
year = {2026},
journal = {Progress in cardiovascular diseases},
doi = {10.1016/j.pcad.2026.08.013},
url = {https://doi.org/10.1016/j.pcad.2026.08.013}
}RIS
TY - JOUR TI - Aficamten is associated with improvements in cardiac mechanics in obstructive hypertrophic cardiomyopathy: Results from FOREST-HCM. AU - Chen ML AU - Hodovan J AU - Masri A AU - Liu V AU - Kim MO AU - Melloni C AU - Jacoby DL AU - Heitner SB AU - Abraham TP PY - 2026 JO - Progress in cardiovascular diseases DO - 10.1016/j.pcad.2026.08.013 UR - https://doi.org/10.1016/j.pcad.2026.08.013 ER -
APA
ML, C., J, H., A, M., V, L., MO, K., C, M., DL, J., SB, H., & TP, A. (2026). Aficamten is associated with improvements in cardiac mechanics in obstructive hypertrophic cardiomyopathy: Results from FOREST-HCM.. Progress in cardiovascular diseases. https://doi.org/10.1016/j.pcad.2026.08.013
Source records
- pubmed · retrieved 2026-09-27T06:20:45.026Z